Please login to the form below

Not currently logged in
Email:
Password:

Janssen named ‘Pharma Company of the Year’ at business intelligence awards

Adelphi Research takes home ‘Agency of the year’ trophy

jj

Now celebrating its twelfth year, the Best of Business Intelligence (BOBI) Awards held in London this week named Janssen its ‘Pharma Company of the Year’.

The Johnson & Johnson pharmaceutical subsidiary saw off strong competition from Sanofi, who was also named runner-up in that category.

The awards, which took place at BHBIA’s annual conference on Tuesday, also saw Adelphi Research UK win the ‘Agency of the year’ award, beating rivals CompuFile Systems and HRW.

Another noteworthy winner of the night was Teva’s Chris Reynolds who, along with David Brown from QlickiT, won the ‘Excellence in Business Analytics’ award.

Janssen saw more success after its group project manager, multiple myeloma, Stephen Ireland - along with Research Partnership’s Jennifer Redfearn and Richard Head - picked up an award for ‘Best Business Impact’.

Scooping the ‘Optimising engagement’ award was Adelphi Research UK’s Joanna Thompson, Rachel Medcalf and Francesca Trewartha along with Roche Products’ Glada Soprani, Karl Wilson and Helen Joyce for their work titled ‘Making a Big Noise with the Voice of the Customer’.

The BHBIA also gave IQVIA’s Richard Gray an award for ‘Best Paper at a One-Day Training Course’ after being voted the best overall presenter at a BHBIA training course over the past 12 months.

Article by
Gemma Jones

17th May 2018

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...